MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study
NCT06543082
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
490
Enrollment
OTHER
Sponsor class
Conditions
Acute Coronary Syndrome
Interventions
DRUG:
Colchicine 0.6 mg
Sponsor
CHA University
Collaborators
[object Object]